Chemistry: molecular biology and microbiology – Vector – per se
Reexamination Certificate
2011-07-12
2011-07-12
Joike, Michele K (Department: 1636)
Chemistry: molecular biology and microbiology
Vector, per se
C435S006120
Reexamination Certificate
active
07977091
ABSTRACT:
The present disclosure provides compositions and methods for utilizing recombinant alphavirus vectors. Also disclosed are compositions and methods for making and utilizing eukaryotic layered vector initiation systems.
REFERENCES:
patent: 5026686 (1991-06-01), Schlesinger et al.
patent: 5091309 (1992-02-01), Schlesinger et al.
patent: 5185440 (1993-02-01), Davis et al.
patent: 5217879 (1993-06-01), Huang et al.
patent: 5466788 (1995-11-01), Alquist et al.
patent: 5505947 (1996-04-01), Johnston et al.
patent: 5532154 (1996-07-01), Brown
patent: 5578475 (1996-11-01), Jessee
patent: 5591579 (1997-01-01), Olivo et al.
patent: 5643576 (1997-07-01), Johnston et al.
patent: 5691177 (1997-11-01), Guber et al.
patent: 5739026 (1998-04-01), Garoff et al.
patent: 5766602 (1998-06-01), Xiong et al.
patent: 5789245 (1998-08-01), Dubensky, Jr. et al.
patent: 5792462 (1998-08-01), Johnston et al.
patent: 5797870 (1998-08-01), March et al.
patent: 5811407 (1998-09-01), Johnston et al.
patent: 5814482 (1998-09-01), Dubensky, Jr. et al.
patent: 5843712 (1998-12-01), Levine
patent: 5843723 (1998-12-01), Dubensky, Jr. et al.
patent: 5851757 (1998-12-01), Olivo et al.
patent: 6342372 (2002-01-01), Dubensky, Jr. et al.
patent: 6376236 (2002-04-01), Dubensky, Jr. et al.
patent: 2200651 (1988-08-01), None
patent: 8800472 (1988-01-01), None
patent: 8910973 (1988-11-01), None
patent: 8910973 (1989-11-01), None
patent: 9102805 (1991-03-01), None
patent: 9206693 (1992-04-01), None
patent: 9210578 (1992-06-01), None
patent: 9417813 (1994-08-01), None
patent: 9426912 (1994-11-01), None
patent: 9507994 (1995-03-01), None
patent: 9517525 (1995-06-01), None
patent: 9519990 (1995-07-01), None
patent: 9525788 (1995-09-01), None
patent: 9527044 (1995-10-01), None
patent: 9531565 (1995-11-01), None
patent: 9527069 (1995-12-01), None
patent: 9532733 (1995-12-01), None
patent: 9617072 (1996-06-01), None
patent: 9537616 (1996-11-01), None
patent: 9639830 (1996-12-01), None
patent: 9716169 (1997-05-01), None
patent: 9724447 (1997-07-01), None
patent: 9730155 (1997-08-01), None
patent: 9738087 (1997-10-01), None
patent: 974446 (1997-11-01), None
patent: 9813511 (1998-04-01), None
patent: 9815636 (1998-04-01), None
patent: 9853077 (1998-05-01), None
patent: 9826084 (1998-06-01), None
patent: 9836779 (1998-08-01), None
patent: 9909192 (1999-02-01), None
patent: 9911808 (1999-03-01), None
patent: 9915641 (1999-04-01), None
patent: 9918226 (1999-04-01), None
patent: 9925858 (1999-05-01), None
patent: 9925859 (1999-05-01), None
patent: 9930734 (1999-06-01), None
Flexner et al., “Attenuation and Immunogenicity in Primates of Vaccinia Virus Recombinants Expressing Human Interleukin-2” Vaccine 8:17-21, 1990.
Hampel et al., “Hairpin Catalytic RNA Model: Evidence for Helices and Sequences Requirement for Substrate RNA” Nucleic Acids Research 18(2):299-304, 1990.
Haseloff et al., “Simple RNA Enzymes with New and Highly Specific Endoribonuclease Activities” Nature 334:585-591, Aug. 1988.
Irvin et al., “Purification and Properties of a Second Antiviral Protein from Phytolacca americana which Inactivates Eukaryotic Ribosomes” Archives of Biochemistry and Biophysics 200(2):418-421, 1980.
Irvin et al., “Purification and Partial Characterization of the Antiviral Protein from Phytolacca americana which Inhibits Eukaryotic Protein Synthesis” Archives of Biochemistry and Biophysics 169:522-2538, 1975.
Jackson et al., “Nucleotide Sequence Analysis of the Structural Genes for Shiga-Like Toxin I encoded by Bacteriophage 900J fromEscherichia coli” Microbial Pathogenesis 2:147-153, 1987.
Kekule et al., “The preS2/S Region of Integrated Hepatitis B Virus DNA Encodes a Transcriptional Transactivator” Nature 361:739-742, 1993.
Lamb et al., “Nucleotide Sequence of Cloned cDNA for Preproricin” Eur. J. Biochem. 148:265-270, 1985.
Levine et al., “Conversion of Lytic to Persistent Alphavirus Infection by the bcl-2 Cellular Oncogene” Nature 361:739-742, 1993.
Maher et al., “Specific Hybridization Arrest of Dihydrofolate Reductase mRNA in Vitro Using Anti-Sense RNA of Anti-Sense Oligonucleotides” Archives of Biochemistry and Biophysics 253(1):214-220, 1987.
Mansour et al., “An adenovirus Vector system Used to Express Polyoma Virus Tumor Antigens” Proc. Natl. Acad. Sci. 82:1359-1363, Mar. 1985.
McKnight, “The Nucleotide Sequence and Transcript map of the Herpes Simplex Virus Thymidine Kinase Gene” Nucleic Acids Research 8(24):5949-5964, 1980.
Mekalanos et al., “Cholera Toxin Genes: Nucleotide Sequence, Deletion Analysis and Vaccine Development” Nature 306:551-557, Dec. 1983.
Nolta et al., “Retroviral Vector-Mediated Gene Transfer into Primitive Human Hemotopoietic Progenitor Cells Effects of Mast Cell Growth Factor (MGF) Combined with Other Cytokines” Exp. Hematol. 20:1065-1071, 1992.
Reed et al., “Oncogenic Potential of bcl-2 Demonstrated by Gene Transfer” Nature 336:259-261, 1988.
Romano et al., Stem Cells, 18:19-39, 2000.
Rosenfeld et al., “Adenovirus-Mediated Transfer of a Recombinant alpha-1-Antitrypsin Gene to the Lung Eptihelium in Vivo” Science 252:431-434, 1991.
Sanchez et al., “Recombinant System for Overexpression of Cholera Toxin B Subunit in Vibrio cholerae as a s basis for Vaccine Development” Proc. Natl. Acad. Sci. 86:481-485, Jan. 1989.
Searle et al., “The Potential of Carboxypeptidase G2-Antibody Conjugates as Anti-Tumor Agents. I. Preparation of Antihuman Chorionic Gonadotrophin-Carboxypeptidase G2 and Cytotoxicity of the Conjugate Against JAP Choriocarcinoma Cells in vivo” Br. J. Cancer 53:377-384, 1986.
Stanton et al., “Nucleotide Sequence Comparison of Normal and Translocated Murine c-myc Genes” Nature 310:423-425, Aug. 1984.
Stripe et al., “Gelonin, a New Inhibitor of Protein Synthesis, Nontoxic to Intact Cells” J. Biological Chemistry 255 (14):6947-6953, 1980.
Wagner et al., “Nucleotide Sequence of the Thymidine Kinase Gene of Herpes Simplex Virus Type 1” Proc. Natl. Acad. Sci. 78(3):1441-1445, Mar. 1981.
Wang et al., “pH-Sensitive Immunoliposomes Mediate Target-cell-Specific Delivery and Controlled Expression of a Foreign Gene in Mouse” Proc. Natl. Acad. Sci. 84:7851-7855, 1987.
Wilson et al., “Prospects for Gene Therapy for Familial Hypercholesterolemia” Mol. Biol. Med. 7:223-232, 1990.
Wu et al., “Targeting Genes: Delivery and Persistent Expression of a Foreign Gene Driven by Mammalian Regulatory elements in Vivo” J. Biological Chemistry 264(29): 16985-16987, 1989.
Yamamoto et al., “The Human LDL Receptor: A Cysteine-Rich Protein with Multiple Alu Sequences in its mRNA” Cell 39:27-38, 1984.
Metsikko et al., “Oligomers of the Cytoplasmic Domain of the p62/E2 Membrane Protein of Semliki Forest Virus Bind to the Nucleocapsid in Vitro” Oct. 1990. J. Virology 64:4678-4683.
Reiss et al., “Newly systhesized class II MHC chains are required for VSV G presentation to CTL clones,” Cellular Immunol. 139:229-238, 1992.
Salk et al., “A strategy for prophylactic vaccination against HIV,” Science 260:1270-1272, 1993.
Dryga et al., “Identification of Mutations in the Sindbis Virus Variant Able to Establish Persistent Infection in BHK Cells: The Importance of a Mutation in the nsP2 Gene,” Virology 228:74-83, 1997.
Tubulekas et al., “Alphavirus expression vectors and their use as recombinant vaccines: a minireview,” Gene. vol. 190:191-195. 1995.
Williams et al., “Introduction of Foreign Genes into Tissue of Living Mice by DNA-Coated Microprojectiles,” Proc. Natl. Acad. Sci. 88:2726-2730, 1991.
Liljestrom et al., “In vitro mutagenesis of a full-length cDNA clone of Semliki Forest Virus: the small 6,000-molecular weight membrane protein modulates virus release,” J. Virology. 65:4107-4113, 1991.
Strauss et al
Belli Barbara A
Chang Stephen M. W.
Driver David A
Dubensky, Jr. Thomas W.
Ibanez Carlos E
Bautista Regina
Joike Michele K
Lee Helen
Novartis Vaccines & Diagnostics, Inc.
LandOfFree
Eukaryotic layered vector initiation systems does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Eukaryotic layered vector initiation systems, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Eukaryotic layered vector initiation systems will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2689646